Ultivue
Cambridge, US · 2 known investors
Vizgen provides spatial multiomics platforms that enable researchers, clinicians, and biopharma teams to map and analyze RNA and protein molecules at single-cell resolution for disease understanding and precision medicine applications. The company merged with Ultivue in 2024 to combine spatial genomics and multiplex proteomic detection capabilities.
AI & Machine LearningBiotechMedical Devices
Investors · 2
In the news
- Vizgen to Merge With Ultivue, Announces Series D Financing | GenomeWebgenomeweb.com · 2024
- Ultivue announces latest financing, leadership update - Ultivueultivue.com · 2023
- Ultivue - Raised $105M Funding from 9 investors - Tracxntracxn.com · 2021
- Public Equity Portfolio News: Ultivue Announces $50 million Financing Round - Ally Bridge Groupally-bridge.com · 2021
- Ultivue Raises $22 Million in Series C Funding - BioSpacebiospace.com · 2019
- Ultivue Inc. : Announces Completion of its Series B Financing | MarketScreenermarketscreener.com · 2018